Feed IDNA
ID

iShares Genomics Immunology and Healthcare ETF IDNA AMEX · Financials · United States

$37.84 -1.51% -$0.58

Summary

iShares Genomics Immunology and Healthcare ETF is an ETF - a fund traded on an exchange like a stock - run by IShares. Positions inside: 61. The ten largest make up 52% of the fund.

Yearly costs
0.47%
Fund size
$339.7M
Positions
61
Dividend yield
0.74%
Running since
2019

What speaks for it

Nothing stands out in its favour.

What to watch

  • The ten largest positions make up 52% of the fund, so its result rests on a few names.
  • In the last five years its price once dropped by 69% from its high.

A fund has no Bulios Score and no Fair Price of its own - both are computed from the results of a single company. This page shows what is inside the fund and what it costs instead.

Price

Performance

1 month
-11%
3 months
-3.8%
This year
+44%
1 year
+46%
3 years
+84%
5 years
-21%
Avg. market cap
$63.7B
P/E
-
Forward P/E
-
P/S
5.4x
P/B
3.4x
P/FCF
-
EV/EBITDA
-
Dividend yield
0.40%
ROIC
-8.5%
ROE
-15.1%
Gross margin
61.3%
Operating margin
-141.7%
Net margin
-146.6%
Payout ratio
-
Net debt/EBITDA
-
Beta
1.11

Weighted average of the 46 largest companies, which make up 97% of the fund. Banks and insurers are left out of the gross margin, the ROIC and the EBITDA figures.

What is inside?

Concentrated
  1. 1
    MR
    Moderna MRNA 14%
  2. 2
    GM
    Genmab A/S GMAB.CO 6.1%
  3. 3
    TW
    Twist Bioscience TWST 4.7%
  4. 4
    BA
    Bayer AG BAYN.DE 4.3%
  5. 5
    RE
    Regeneron Pharmaceuticals REGN 4.3%
  6. 6
    45
    Takeda Pharmaceutical Company Limited 4502.T 4.0%
  7. 7
    EX
    Exelixis EXEL 3.8%
  8. 8
    MR
    Merck & Co. MRK 3.5%
  9. 9
    VR
    Vertex Pharmaceuticals VRTX 3.5%
  10. 10
    IN
    Incyte INCY 3.4%

Positions in the fund: 61. The ten largest make up 52% of it.

Composition as of Nov 14, 2026.

Where is it spread?

Spread out

By country

By company size

By the company's market value: Mega cap from $200B, Large cap from $10B, Mid cap from $2B, Small cap from $300M, Micro cap below $300M.

Largest country: United States (64%). Largest size group: Large cap (57%).

What does it cost me?

Usual costs
A year from $10,000
$47.00
Over 20 years
$2,277

From every $10,000 invested the fund takes $47.00 a year. You do not pay it separately - it is taken out of the fund's value. Over 20 years at 5% yearly growth that adds up to about $2,277.

How has it done?

Losing value
A year on average, 5 years
-4.5%
Deepest drop
-69%
Yearly volatility
31%

Average yearly decline over the last five years: 4.5%. Deepest drop in these years: 69% below the earlier high.

Does it pay dividends?

Yes, it pays out
Yield
0.74%
Payments a year
2
Last payment
$0.13

Over the last 12 months it paid $0.28 per share, which is 0.74% of today's price. The last payment was $0.13 on Jun 15, 2026.

Is it easy to buy and sell?

Yes
Traded a day
$4.87M
Shares a day
129K

On an average day about $4.87M of the fund changes hands.

How expensive are the companies inside?

Rather expensive
Average Bulios Score
44 out of 100

Weight by Bulios Fair Price

By Fair Price, 53% of the rated weight comes out as overvalued.

Counted from its largest companies (46), which make up 97% of the fund. Each company counts by its weight. We use the metrics, the Bulios Score and the Fair Price of the companies themselves.

Similar funds

Funds that hold much of the same. The overlap says how much of their weight they share with this fund.

Fund Domicile Size 1-year change Dividends
GN
GNOM Global X - Genomics & Biotechnology ETF
United States 0.50% $102.7M +40% Pays out 30%
GN
GNMX Corgi ETF Trust I - Corgi Genomics & Precision Medicine ETF
United States 0.35% $1.91M - - 29%
20
203780.KS MiraeAsset TIGER NASDAQ BIO ETF
South Korea 0.30% $79.3M +12% Reinvests 24%
BI
BIOTEC.JO UBS BiotechTop50 27Jun28
United Kingdom 0.50% $2.32M - Reinvests 24%
BB
BBP Virtus Biotech ETF
United States 0.34% $41.6M +30% Reinvests 23%
SB
SBIO.MI Invesco NASDAQ Biotech UCITS ETF
Ireland 0.40% $651.6M +31% Reinvests 23%

We use essential cookies to run the website and optional analytics cookies to measure usage.

Privacy policy